Rimiducid (AP1903) is a dimerizer agent that acts by cross-linking theFKBPdomains. Rimiducid (AP1903) dimerizes theCaspase 9suicide switch and rapidly inducesapoptosis.

EC50: 0.1 nM (FKBP, in HT1080 cells)^[1]
Fas receptor^[1]

The human fibrosarcoma line HT1080 is engineered to express stably a fusion protein comprising a myristoylation sequence, two copies of F36V-FKBP, and the human first apoptosis signal (Fas) intracellular domain. Rimiducid (AP1903) elicits potent and dose-dependent apoptotic death of these engineered cells in culture, with an EC₅₀of ≈0.1 nM^[1]. Maximal killing occurred in the presence of 3 to 10 nM Rimiducid (AP1903), and the IC₅₀is approximately 0.2 nM. LV′VFas-transduced T lymphocytes expressing high levels of CD25 (top panel) are eliminated by with 66%±7.5% (n=10) efficiency. When cells are examined after CD25 expression returned to basal levels, 63%±4.7% (n=9) killing is observed after Rimiducid treatment^[2].

Rimiducid (AP1903; i.v.,0.01, 0.1, 1, 10, and 100 mg/kg) elicits a dose-dependent decrease in serum human GH levels, with a half-maximal effective dose of 0.4±0.1 mg/kg^[1].

1411.63

Solid

C₇₈H₉₈N₄O₂₀

195514-63-7

Room temperature in continental US; may vary elsewhere.

*该半岛bd体育手机客户端 在溶液状态不稳定，建议您现用现配，即刻使用。

DMSO : 50 mg/mL(35.42 mM;Need ultrasonic)

请根据半岛bd体育手机客户端 在不同溶剂中的溶解度，选择合适的溶剂配制储备液；该半岛bd体育手机客户端在溶液状态不稳定，建议您现用现配，即刻使用。

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

• 1.

  请依序添加每种溶剂： 10% DMSO90%corn oil

  Solubility: ≥ 2.5 mg/mL (1.77 mM); Clear solution

  此方案可获得 ≥ 2.5 mg/mL (1.77 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

  以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。